First phase: A three months lasting feasibility study
will be conducted in order to evaluate the use,
reliability and patient satisfaction with symptom
monitoring (subjective information). Patients under
usual treatment will use a smartphone with the
SIMPLe version 1.0 application installed. The
intervention will be consecutively offered to 30
stable adults (>18 years) fulfilling the inclusion
criteria described below. An informed consent will
be handled and explained and must be signed in
order to participate. Sociodemographic data and
standardized clinical as well as functional
assessments will be administered at baseline and
monthly for three months.